tiprankstipranks
Trending News
More News >
Cero Therapeutics Holdings, Inc. (CERO)
OTHER OTC:CERO
US Market

CERo Therapeutics Holdings (CERO) Income Statement

Compare
496 Followers

CERo Therapeutics Holdings Income Statement

Last quarter (Q3 2025), CERo Therapeutics Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, CERo Therapeutics Holdings's net income was $-11.51M. See CERo Therapeutics Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -1.16M$ -1.12M$ 0.00$ 0.00
Operating Expenses
$ 15.30M$ 2.93M$ 2.91M$ 431.50K
Depreciation and Amortization
$ 1.16M$ 2.93K$ 2.91M$ 735.47K
EBITDA
$ -6.57M$ -2.44M$ -68.58K$ 403.06K
Operating Income
$ -15.30M$ -2.93M$ -2.91M$ -332.03K
Other Income/Expenses
$ 7.57M$ 491.57K$ 2.84M$ -385.00
Pretax Income
$ -7.73M$ -2.44M$ -68.58K$ -332.42K
Net Income
$ -7.73M$ -2.54K$ -667.74K$ -315.55K
Per Share Metrics
Basic EPS
$ -6.87$ -2.50K$ -19.73$ -2.75
Diluted EPS
$ -6.87$ -2.50K$ -19.73$ -2.75
Weighted Average Shares Outstanding
120.79K 7.35K 7.35K 7.35K
Weighted Average Shares Outstanding (Diluted)
120.79K 7.35K 7.35K 7.35K
Currency in USD

CERo Therapeutics Holdings Earnings and Revenue History